UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

_________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

_________________

Date of Report (Date of earliest event reported): December 8, 2014

InspireMD, Inc.

(Exact name of registrant as specified in its charter)

Registrant’s telephone number, including area code: (857) 453-6553

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))

On December 8, 2014, InspireMD, Inc. (the “Company”) held its 2014 annual meeting of stockholders (the “Annual Meeting”). As previously reported in the Company’s definitive proxy statement dated October 27, 2014 (the “2014 Proxy”), the term of the Company’s Class 3 directors, Campbell Rogers, M.D. and James Barry, Ph.D., was scheduled to expire at the Annual Meeting and the Board nominated each of Drs. Rogers and Barry for reelection at the Annual Meeting as Class 3 directors.

At the Annual Meeting, Drs. Rogers and Barry were each elected as a Class 3 member of the Board to serve for a term expiring at the Company’s 2017 annual meeting of stockholders.

For more information about the matters above, see the Company’s 2014 Proxy, the relevant portions of which are incorporated herein by reference.

At the Annual Meeting, the following two proposals were submitted to the Company’s stockholders:

For more information about the foregoing proposals, see the Company’s 2014 Proxy. Holders of the Company’s common stock were entitled to one vote per share. The number of votes cast for and against and the number of abstentions and broker non-votes with respect to each matter voted upon are set forth below:

The results reported above are final voting results. No other matters were considered or voted upon at the meeting.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.